Physician profile
Brian S Page
NPI 1245219336
$3,964.64
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,411 · 2020: $1,588 · 2021: $532 · 2022: $281 · 2024: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,029.50 | 2019-2022 | |
| Depuy Synthes Sales INC. | $250.59 | 2019-2022 | |
| Boston Scientific Corporation | $223.50 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Vertos Medical, INC. | $114.82 | 2024 | Mild Device Kit |
| Medtronic USA, INC. | $95.76 | 2019-2020 | |
| Gilead Sciences, INC. | $46.00 | 2019 | |
| Radius Health, INC. | $42.65 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $40.82 | 2019 | |
| Nevro Corp. | $34.15 | 2019 | |
| Pacira Therapeutics, INC. | $22.02 | 2019 | |
| Nalu Medical, INC. | $20.57 | 2021 | |
| Biodelivery Sciences International, INC. | $16.43 | 2020 | |
| Scilex Pharmaceuticals INC. | $11.02 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $9.50 | 2019 | |
| Electronic Waveform Lab, INC. | $7.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Page listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.